Literature DB >> 6712176

Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia.

G Stoica, A Koestner, C C Capen.   

Abstract

Intraperitoneal administration of high doses (45, 90, and 180 mg/kg of ENU (N-ethyl-N-nitrosourea) to 30-day-old female Sprague-Dawley (CD) rats resulted in a high incidence (greater than 100%) of mammary tumors (MT), of which 95% were malignant. The mean induction time was 92 days for the high dose group. There was a definite dose-effect relationship. As the dose of ENU decreased the number of rats affected and number of tumors per rat decreased, but the survival time and mean induction time increased. At the time of death 7.5% of mammary tumors had metastasized to the lung. A variety of histological MT types were produced simulating breast tumors in women. In addition to MT, a number of rats developed primary tumors in other organs (brain, ovary, kidney, and hemic-lymphatic system). The high MT incidence, high rate of malignancy, short latent period, and the simulation of human breast tumor types suggest this experimental design to be a valuable animal model to study initiation, hormone dependency, and pathogenesis of mammary neoplasia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712176

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Stephanie Corn; Abraham Schneider; Laurie K McCauley
Journal:  Cancer Treat Res       Date:  2004

2.  Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation.

Authors:  Anda Preda; Viktor Novikov; Martina Möglich; Eugenia Floyd; Karl Turetschek; David M Shames; Timothy P L Roberts; Claire Corot; Wayne O Carter; Robert C Brasch
Journal:  Eur Radiol       Date:  2005-07-13       Impact factor: 5.315

3.  Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations.

Authors:  Aarifa Nazmeen; Smarajit Maiti
Journal:  Mol Biol Rep       Date:  2018-10-12       Impact factor: 2.316

4.  Structure-activity relationships in the induction of mammary gland neoplasia in male rats with substituted aminopyrazoles.

Authors:  J E Fitzgerald; E J McGuire; L K Andrews; F A de la Iglesia
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

Review 5.  Animal Models of Bone Metastasis.

Authors:  J K Simmons; B E Hildreth; W Supsavhad; S M Elshafae; B B Hassan; W P Dirksen; R E Toribio; T J Rosol
Journal:  Vet Pathol       Date:  2015-05-28       Impact factor: 2.221

6.  Automating tumor classification with pixel-by-pixel contrast-enhanced ultrasound perfusion kinetics.

Authors:  Casey N Ta; Yuko Kono; Christopher V Barback; Robert F Mattrey; Andrew C Kummel
Journal:  J Vac Sci Technol B Nanotechnol Microelectron       Date:  2012-03-22

7.  Mammary tumors in Sprague Dawley rats induced by N-ethyl-N-nitrosourea for evaluating terahertz imaging of breast cancer.

Authors:  Nagma Vohra; Tanny Chavez; Joel R Troncoso; Narasimhan Rajaram; Jingxian Wu; Patricia N Coan; Todd A Jackson; Keith Bailey; Magda El-Shenawee
Journal:  J Med Imaging (Bellingham)       Date:  2021-04-26

8.  High-Fat, High-Calorie Diet Enhances Mammary Carcinogenesis and Local Inflammation in MMTV-PyMT Mouse Model of Breast Cancer.

Authors:  Sarah Cowen; Sarah L McLaughlin; Gerald Hobbs; James Coad; Karen H Martin; I Mark Olfert; Linda Vona-Davis
Journal:  Cancers (Basel)       Date:  2015-06-26       Impact factor: 6.639

9.  N-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.

Authors:  Satish Bodakuntla; Anandi V Libi; Surojit Sural; Prasad Trivedi; Mayurika Lahiri
Journal:  BMC Cancer       Date:  2014-04-24       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.